Skip to main content
SpringerLink
Log in

A Standardized Mini Paddle Apparatus as an Alternative to the Standard Paddle

  • Brief/Technical Note
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  1. Dissolution testing of immediate release solid oral dosage forms; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997.

  2. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 2000.

  3. A. Scholz, E. Kostewicz, B. Abrahamsson, and J.B. Dressman. Can the USP paddle method be used to represent in-vivo hydrodynamics. J. Pharm. Pharmacol. 55(4):443–451 (2003).

    Article  PubMed  CAS  Google Scholar 

  4. Y. Wu, D.O. Kildsig, and E.S. Ghaly. Effect of hydrodynamic environment on tablets dissolution rate. Pharm. Dev. Technol. 9(1):25–37 (2004).

    Article  PubMed  CAS  Google Scholar 

  5. S. Diebold. Physiological parameters relevant to dissolution testing: hydrodynamic considerations. In J.B. Dressman, and J. Kraemer (eds.), Pharmaceutical dissolution testing, Taylor & Francis, Boca Raton, FL, 2005, pp. 127–191.

    Google Scholar 

  6. M. Lindenberg, S. Kopp, and J.B. Dressman. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58(2):265–278 (2004).

    Article  PubMed  Google Scholar 

  7. N.A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernas, A.S. Hussain, H.E. Junginger, S.A. Stavchansky, K.K. Midha, V.P. Shah, and G. Amidon. Molecular properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification. Mol. Pharm. 1(1):85–96 (2004).

    Article  PubMed  CAS  Google Scholar 

  8. C.Y. Wu, and L.Z. Benet. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22(1):11–23 (2005).

    Article  PubMed  CAS  Google Scholar 

  9. S. Klein. The mini paddle apparatus—a useful tool in the early developmental stage? Experiences with immediate release dosage forms. Dissolution Technologies. 13(4):6–11 (2006).

    Google Scholar 

  10. J.W. Moore, and H.H. Flanner. Mathematical comparison of dissolution profiles. Pharm. Technol. 20:64–74 (1996).

    Google Scholar 

  11. V.P. Shah, Y. Tsong, P. Sathe, and R.L. Williams. Dissolution profile comparison using similarity factor, f2. Dissolution Technol. 6(3):15 (1999).

    Google Scholar 

  12. V.P. Shah, Y. Tsong, P. Sathe, and J.P. Liu. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f2. Pharm. Res. 15(6):889–896 (1998).

    Article  PubMed  CAS  Google Scholar 

  13. Extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997.

  14. SUPAC-MR: modified release solid oral dosage forms. Scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 1997.

  15. Oral extended (controlled) release dosage forms in vivo bioequivalence and in vitro dissolution testing; Guidance for Industry; U.S. Department of Health and Human Services, Food and Drug Administration, Office of Generic Drugs, U.S. Government Printing Office: Washington, DC, 1993.

  16. T. Mirza, J. Yatindra, J.L. Qian, and R. Vivilecchia. Evaluation of dissolution hydrodynamics in the USP, Peak™ and Flat-Bottom Vessels using different solubility drugs. Dissolution Technol. 12(1):11–16 (2005).

    CAS  Google Scholar 

Download references

Acknowledgement

The authors would like to thank ERWEKA GmbH, Heusenstamm, Germany for the provision of the mini paddle test equipment.

Author information

Authors and Affiliations

  1. Institute of Pharmaceutical Technology, Goethe University Frankfurt, 9 Max von Laue Street, Frankfurt, 60438, Germany

    Sandra Klein

  2. Pharmaceutical Consultant, North Potomac, MD, 20878, USA

    Vinod P. Shah

Authors
  1. Sandra Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinod P. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandra Klein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klein, S., Shah, V.P. A Standardized Mini Paddle Apparatus as an Alternative to the Standard Paddle. AAPS PharmSciTech 9, 1179–1184 (2008). https://doi.org/10.1208/s12249-008-9161-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9161-6

Key words

Search

Navigation